Pharmacophore modeling and three-dimensional database searching for drug design using catalyst
Y Kurogi, OF Guner - Current medicinal chemistry, 2001 - ingentaconnect.com
… Clearly established as one of the successful computational tools in rational drug design,
we present in this review article a brief history of the evolution of this technology and detailed …
we present in this review article a brief history of the evolution of this technology and detailed …
Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances
O Guner, O Clement, Y Kurogi - Current medicinal chemistry, 2004 - ingentaconnect.com
… Computational approaches to drug design often involve a combination of techniques and
tools. This provides a complementary approach to identifying and optimizing novel lead …
tools. This provides a complementary approach to identifying and optimizing novel lead …
3D database searching in drug design
YC Martin - Journal of Medicinal Chemistry, 1992 - ACS Publications
… for thetemplate-based design of potential dopaminergics.5 We performed geometric searches
on three databases. Our program mutates the database molecules identified into those to …
on three databases. Our program mutates the database molecules identified into those to …
Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design
PG Francoeur, T Masuda, J Sunseri, A Jia… - Journal of chemical …, 2020 - ACS Publications
… We believe our CrossDocked2020 data set provides a close approximation of the desired
domain of a general-purpose model for structure-based drug design. Importantly, although the …
domain of a general-purpose model for structure-based drug design. Importantly, although the …
WHAT IF: a molecular modeling and drug design program
G Vriend - Journal of molecular graphics, 1990 - Elsevier
… drug design. X-ray diffraction and nuclear magnetic resonance techniques are improving
rapidly, but nevertheless it is unlikely that the three-dimensional … Any three-dimensional data …
rapidly, but nevertheless it is unlikely that the three-dimensional … Any three-dimensional data …
Structure-based drug design
TL Blundell - Nature, 1996 - nature.com
… Here I describe recent progress in using such knowledge of the three-dimensional structures
of receptor or target proteins as a basis for drug design. Three-dimensional structures and …
of receptor or target proteins as a basis for drug design. Three-dimensional structures and …
Modelling three-dimensional protein structures for applications in drug design
T Schmidt, A Bergner, T Schwede - Drug discovery today, 2014 - Elsevier
… In this sense, drug design is an enterprise that aims to engineer molecules with a controlled
interaction profile against a multitude of different target and off-target proteins in an organism…
interaction profile against a multitude of different target and off-target proteins in an organism…
Searching techniques for databases of two-and three-dimensional chemical structures
P Willett - Journal of Medicinal Chemistry, 2005 - ACS Publications
… a clustering of a data set, which in the context of this paper we will assume is a database of
2D chemical structures. First, each of the molecules in the database must be characterized by …
2D chemical structures. First, each of the molecules in the database must be characterized by …
Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors
H Matter - Journal of Medicinal Chemistry, 1997 - ACS Publications
… improved using design techniques to maximize the diversity of structure databases or …
However, this database was the only public data collection available for this purpose, when …
However, this database was the only public data collection available for this purpose, when …
Chemogenomic approaches to rational drug design
D Rognan - British journal of pharmacology, 2007 - Wiley Online Library
… By definition, analysing chemogenomic data is a never-ending learning process aimed at
completing a two-dimensional (2-D) matrix, where targets/genes are usually reported as …
completing a two-dimensional (2-D) matrix, where targets/genes are usually reported as …
相关搜索
- drug design three dimensional database
- drug design data bases
- deep learning in drug design
- molecular modeling in drug design
- strategies for drug design
- computational drug design
- drug design visualisation aid
- drug design structure function analysis
- rational drug design
- drug design protein structure
- drug design protein targets
- drug design convolutional neural networks
- databases of three dimensional chemical structures
- three dimensional molecular descriptors structure databases
- pharmacophore modeling three dimensional database
- drug design binding affinity prediction